Psychotherapeutic considerations in pharmacological trials

Alcoholism: Clinical and Experimental Research

Volumn 20, Issue 7 SUPPL., 1996, Pages

  O'Malley, Stephanie S ^a   Carroll, Kathleen M ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Drug Effects; Naltrexone; Pharmacotherapeutic Efficacy; Treatment Matching

Indexed keywords

NALTREXONE;

ALCOHOL ABUSE; ALCOHOLISM; CONFERENCE PAPER; DRUG EFFICACY; HUMAN; PATIENT COMPLIANCE; PRIORITY JOURNAL; PSYCHOSOCIAL CARE; TREATMENT OUTCOME;

EID: 0029989342     PISSN: 01456008     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1530-0277.1996.tb01185.x     Document Type: Conference Paper

References (49)

1. Fuller RK, Branchey L, Brightwell DR, Derman RM, Emrick CD, Iber FL, James KE, Lacoursiere RB, Lee KK, Lowenstam I, Maany I, Neiderhiser D, Nocks JJ, Shaw S: Disulfiram treatment of alcoholism: A Veterans Administration Cooperative Study. JAMA 256:1449-1455, 1986
2. Institute of Medicine: Broadening the Base of Treatment for Alcohol Problems: Report of a Study by a Committee of the Institute of Medicine, Division of Mental Health and Behavioral Medicine. Washington, D.C., National Academy of Sciences, 1990
3. Anton RF: Medications for treating alcoholism. Alcohol Health Res World 18:265-271, 1994
4. Anton RF: New directions in the pharmacotherapy of alcoholism. Psychiatr Ann 25:353-362, 1995
5. Kranzler HR, Anton RF: Implications of recent neuropsychopharmacologic research for understanding the etiology and development of alcoholism. J Consult Clin Psychol 62:1116-1126, 1994
6. Moak DH, Anton RF, Malcolm R, Randall CL, Brady K: Alcoholic subjects with anxiety disorder: Characteristics of completers and noncompleters in a pharmacologic study. Am J Addict 2:39-47, 1993
7. Aronson JK, Hardman M: ABC of monitoring drug therapy: Patient compliance. Br Med J 305:1009-1011, 1992
8. Bond WS, Hussar DA: Detection methods and strategies for improving medication compliance. Am J Hosp Pharm 48:1978-1988, 1991
9. Kranzler HR, Mason BJ, Pettinati H, Anton RF: Methodological issues in clinical trials with alcoholics, in Hertzman M, Feltner D (eds): Clinical Trials of CNS Drugs. New York, New York University Press (in press)
10. O'Brien CP, Volpicelli LA, Volpicelli JR: Naltrexone in the treatment of alcoholism: A clinical review. Alcohol 13:35-39, 1996
11. Lasagna L: Commentary on "Improvement of phase III psychotropic drug trials by intensive phase II work." Neuropsychopharmacology 4:263-264, 1991
12. Feinstein AR: 'Compliance bias' and the interpretation of therapeutic trials, in Haynes RB, Taylor DW, Sackett DL (eds): Compliance in Health Care. Baltimore, Johns Hopkins University Press, 1979, pp 309- 322
13. Lavori PW: Clinical trials in psychiatry: Should protocol deviation censor patient data? Neuropsychopharmacology 6:39-48, 1992
14. Lee YJ, Ellenberg JH, Hirtz DG, Nelson KB: Analysis of clinical trials by treatment actually received: Is it really an option? Stat Med 10:1595-1605, 1991
15. O'Malley SS: Integration of opioid antagonists and psychosocial therapy in the treatment of narcotic and alcohol dependence. J Clin Psychiatry 56(Suppl.):30-38, 1995
16. Baekeland F, Lundwall L: Dropping out of treatment: A critical review. Psychol Bull 82:738-783, 1975
17. Wickizer T, Maynard C, Atherly A, Frederick M, Koepsell T, Krupski A, Stark K: Completion rates of clients discharged from drug and alcohol treatment programs in Washington state. Am J Public Health 84:215-221, 1994
18. Callahan EJ, Rawson RA, McCleave B, Arias R, Glazer M, Liberman RP: The treatment of heroin addiction: Naltrexone alone and with behavior therapy. Int J Addict 15:795-807, 1980
19. McLellan AT, Arndt IO, Metzger DS, Woody GE, O'Brien CP: The effects of psychosocial services in substance abuse treatment. JAMA 269:1953-1959, 1993
20. Ball JC, Ross A: The Effectiveness of Methadone Maintenance Treatment: Patients, Programs, Services, and Outcome. New York, Springer-Verlag, 1991
21. Allen JP, Litten RZ: Techniques to enhance compliance with disulfiram. Alcohol Clin Exp Res 16:1035-1041, 1992
22. O'Farrell TJ, Cutter HSG, Choquette KA, Floyd FJ, Bayog RD: Behavioral marital therapy for male alcoholics: Marital and drinking adjustment during the two years after treatment. Behav Ther 23:529-549, 1992
23. Grabowski J, O'Brien CP, Greenstein R, Long M, Steinberg-Donato S, Ternes J: Effects of contingent payments on compliance with a naltrexone regimen. Am J Drug Alcohol Abuse 6:355-365, 1979
24. Meyer RE, Mirin SM, Altman JL, McNamee HB: A behavioral paradigm for the evaluation of narcotic antagonists. Arch Gen Psychiatry 33:371-377, 1976
25. Woody GE, Luborsky L, McLellan AT, O'Brien CP, Beck AT, Blaine J, Herman I, Hole A: Psychotherapy for opiate addicts: Does it help? Arch Gen Psychiatry 40:639-645, 1983
26. Resnick RB, Washton AM, Stone-Washton N: Psychotherapy and naltrexone in opioid dependence, in Harris LS (ed): Problems of Drug Dependence 1980. National Institute on Drug Abuse (NIDA) Research Monograph 34. Washington, D.C., U.S. Government Printing Office, 1981
27. O'Malley SS, Jaffe A, Chang G, Witte G, Schottenfeld RS, Rounsaville BJ: Naltrexone in the treatment of alcohol dependence: Preliminary findings, in Naranjo C (ed): Novel Pharmacological Interventions for Alcoholism. New York, Springer-Verlag, 1992, p 148
28. Meichenbaum D, Turk DC: Facilitating Treatment Adherence: A Practitioner's Handbook. New York, Plenum Press, 1987
29. Cramer JA, Spilker B (eds): Patient Compliance in Medical Practice and Clinical Trials. New York, Raven Press, Ltd., 1991
30. Hunt GM, Azrin NH: A community-reinforcement approach to alcoholism. Behav Res Ther 11:91-104, 1973
31. Rode S, Meandzija B, O'Connor P, Jaffe A, Rounsaville B, O'Malley S: Compliance with naltrexone: Pill counts vs MEMS cap reading, abstract. Alcohol Clin Exp Res 18:465, 1994
32. Kofoed LL: Chemical monitoring of disulfiram compliance: A study of alcoholic outpatients. Alcohol Clin Exp Res 11:481-485, 1987
33. Azrin NH: Improvements in the community-reinforcement approach to alcoholism. Behav Res Ther 14:339-348, 1976
34. O'Malley SS, Jaffe AJ, Chang G, Schottenfeld RS, Meyer RE, Rounsaville B: Naltrexone and coping skills therapy for alcohol dependence: A controlled study. Arch Gen Psychiatry 49:881-887, 1992
35. Kranzler HR, Burleson JA, Korner P, Del Boca FK, Bohn MJ, Brown J, Liebowitz N: Placebo-controlled trial of fluoxetine as an adjunct to relapse prevention in alcoholics. Am J Psychiatry 152:391-397, 1995
36. 3 antagonist ondansetron in alcohol abuse and dependence. Alcohol Clin Exp Res 18:879-885, 1994
37. Miller WR, Zweben A, DiClemente CC, Rychtarik RG: Motivational Enhancement Therapy Manual: A Clinical Research Guide for Therapists Treating Individuals with Alcohol Abuse and Dependence (NIAA Project MATCH Monograph Series, volume 2, DHHS Publication no. [ADM] 92-1894). Rockville, MD, National Institute on Alcohol Abuse and Alcoholism, 1992
38. Carroll KM, Rounsaville BJ, Gordon LT, Nich C, Jatlow P, Bisighini RM, Gawin FH: Psychotherapy and pharmacotherapy for ambulatory cocaine abusers. Arch Gen Psychiatry 51:177-187, 1994
39. Higgins ST, Budney AJ, Bickel WK, Hughes JR, Foerg F, Badger G: Achieving cocaine abstinence with a behavioral approach. Am J Psychiatry 150:763-769, 1993
40. Carroll KM, Kadden RM, Donovan DM, Zweben A, Rounsaville BJ: Implementing treatment and protecting the validity of the independent variable in treatment matching studies. J Stud Alcohol (Suppl. 12): 149-155, 1994
41. Project MATCH Research Group: Project MATCH: Rationale and methods for a multisite clinical trial matching patients to alcoholism treatment. Alcohol Clin Exp Res 17:1130-1145, 1993
42. Elkin I, Pilkonis PA, Docherty JP, Sotsky SM: Conceptual and methodological issues in comparative studies of psychotherapy and pharmacotherapy. I. Active ingredients and mechanisms of change. Am J Psychiatry 145:909-917, 1988
43. Crits-Christoph P, Mintz J: Implications of therapist effects for the design and analysis of comparative studies of psychotherapies. J Consult Clin Psychol 59:20-26, 1991
44. Carroll KM, Nuro K: Treatment manuals and treatment compliance, in Carroll KM: Facilitating Compliance in Alcohol Treatment (NIAA Project MATCH Monograph Series). Rockville, MD, National Institute on Alcohol Abuse and Alcoholism (in press)
45. Crits-Christoph P, Baranackie K, Kurcias J, Beck AT, Carroll K, Perry K, Luborsky L, McLellan AT, Woody G, Thompson L, Gallagher D, Zitrin C: Meta-analysis of therapist effects in psychotherapy outcome studies. Psychotherapy Res 1:81-91, 1991
46. Nowinski J, Baker S, Carroll KM: Twelve-step Facilitation Therapy Manual: A Clinical Research Guide for Therapists Treating Individuals with Alcohol Abuse and Dependence (NIAA Project MATCH Monograph Series, volume 1, DHHS Publication no. [ADM] 92-1893). Rockville, MD, National Institute on Alcohol Abuse and Alcoholism, 1992
47. Kadden R, Carroll KM, Donovan D, Cooney N, Monti P, Abrams D, Litt M, Hester R: Cognitive-Behavioral Coping Skills Therapy Manual: A Clinical Research Guide for Therapists Treating Individuals with Alcohol Abuse and Dependence. (NIAA Project MATCH Monograph Series, volume 3, DHHS Publication no. [ADM] 92-1895). Rockville, MD, National Institute on Alcohol Abuse and Alcoholism, 1992
48. Carroll KM, Rounsaville BJ, Nich C: Use of observer and therapist ratings to monitor delivery of coping skills treatment for cocaine abusers: Utility of therapist session checklists. Psychother Res (in press)
49. McLellan AT, Alterman AI, Cacciola J, Metzger D, O'Brien CP: A new measure of substance abuse treatment: Initial studies of the treatment services review. J Nerv Ment Dis 180:101-110, 1992